🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Foxtale's revenue soars to Rs 83 Cr in FY24, losses widen

EntrackrEntrackr · 1y ago
Foxtale's revenue soars to Rs 83 Cr in FY24, losses widen
Medial

Foxtale, a direct-to-consumer (D2C) skincare brand, reported Rs 83 crore of revenue in its third full fiscal year, which ended in March 2024. However, in pursuit of scale, the losses for the Mumbai-based company crossed Rs 50 crore in the same period. Foxtale’s revenue from operations surged around 6X to Rs 83 crore in FY24 from Rs 14 crore in FY23, its annual financial statements sourced from the Registrar of Companies show. Founded in 2021 by Romita Mazumdar, Foxtale is an affordable skincare brand focused on products designed for Indian skin. Its products target issues such as acne, aging, and hyperpigmentation. The brand's products are available on its website and various marketplaces, including Nykaa, Amazon, Blinkit, Flipkart, and Myntra. The sale of skin and beauty products was Foxtale's sole source of revenue in the previous fiscal year. Similar to other D2C skincare brands, Foxtale spent Rs 50 crore on advertising and promotion, which is 36% of its overall cost. This cost saw an increase of 3.8X during FY24. To the tune of scale, its cost of procurement grew 5.8X to Rs 35 crore in the previous fiscal. Foxtale's employee benefit expenses, including salaries, provident fund (PF), gratuity, and ESOPs, surged 2.8x to Rs 20 crore in FY24. Its delivery, legal, outsourcing manpower, and other overheads pushed the overall expenditure to Rs 139 crore in FY24 from Rs 33 crore in FY23. Despite registering 6x fold in scale, higher advertising expenses and employee benefit costs drove Foxtale's losses up by 189% to Rs 55 crore in FY24, compared to Rs 19 crore in FY23. On a unit level, it spent Rs 1.67 to earn a rupee of operating revenue. At the end of FY24, its current assets were recorded at Rs 69 crore, including cash and bank balances of Rs 44 crore. Foxtale has emerged as one of the few D2C startups to secure $48 million across two funding rounds in just seven months. Its latest $30 million round was spearheaded by Japanese beauty products giant, Kose Corporation. Its major competitors include Sugar Cosmetics, WOW Skin Science, Plum, MamaEarth, Minimalist, and several others.

D2C skincare brand Foxtale raises $30 Mn

EntrackrEntrackr · 1y ago
D2C skincare brand Foxtale raises $30 Mn
Medial

Foxtale, a direct-to-consumer (D2C) skincare brand, has secured $30 million (approximately Rs 250 crore) in a funding round led by Japanese beauty products company Kose Corporation. Existing investors Z3Partners (formerly Matrix Partners India), Kae Capital, and Panthera Growth Partners also participated in this round. This marks Foxtale's second capital infusion within a year, following an $18 million round in June 2024. The company plans to utilize the fresh capital to expand its product range and enhance its online presence. Foxtale, founded by Romita Mazumdar in 2021, is an affordable skincare brand focused on products designed for Indian skin, targeting issues such as acne, aging, and hyperpigmentation. Its products are available on its website and various marketplaces, including Nykaa, Amazon, Blinkit, Flipkart, and Myntra. According to the company, 50% of its revenue comes from its website, 40% from online marketplaces and quick commerce platforms, and the remaining 10% from offline sales channels. Founder and CEO Mazumdar claimed that Foxtale is on track to surpass Rs 300 crore in gross revenue in the current fiscal year. Foxtale competes with well-established players like Sugar Cosmetics, WOW Skin Science, Plum, MamaEarth, Minimalist, and several others.

D2C skincare brand Foxtale scoops up $14 Mn in new round

EntrackrEntrackr · 1y ago
D2C skincare brand Foxtale scoops up $14 Mn in new round
Medial

D2C skincare brand Foxtale has raised Rs 119.5 crore (approximately $14 million) in a new round from PGP India Growth, Panthera Growth, Matrix Partners, and Beacon Trusteeship. This is the first funding round for the Mumbai-based firm in 2024 and the second in the past two years. Previously, the startup had raised $4 million in a pre-Series A round from Matrix and Kae Capital in June 2022 and a seed round in August 2021. Founded by Romita Mazumdar in 2021, Foxtale is a low-cost skincare brand that launched four basic products. Its product portfolio covers anti-aging, acne control and hydration aspects among others. According to the startup data intelligence platform TheKredible, the three-year-old company has been valued at around Rs 790 crore or $96 million (post-allotment of the new round). Foxtale grew at a scorching pace in the last fiscal year and posted Rs 13.8 crore in operating revenue against Rs 20 lakh in FY22. However, the firm’s losses soared 7.5-fold to Rs 18.49 crore during the fiscal year ending March 2023 as compared to Rs 2.48 crore in FY22. The company claimed that it hit break even in Q2 in FY24 and intends to become a Rs 1,000 crore brand in the next five years. Foxtale will compete with well established players like Sugar Cosmetics, WOW Skin Science, Plum, MamaEarth, Minimalist and several others. Foxtale’s funding is good news for the D2C skincare ecosystem which didn’t see much funding activities in the past year. Sugar has been eyeing to score around $100 million in secondary and primary capital but the deal is yet to be materialized.

Foxtale’s revenue nears Rs 200 Cr in FY25; losses jump 38%

EntrackrEntrackr · 23d ago
Foxtale’s revenue nears Rs 200 Cr in FY25; losses jump 38%
Medial

Foxtale, a direct-to-consumer skincare and beauty brand, continued its strong growth momentum in FY25 as it scaled up aggressively. However, the Mumbai-based company remained in the red due to a sharp rise in expenses. Foxtale’s revenue from operations grew 2.4x to Rs 199 crore in FY25 from Rs 83 crore in FY24, according to its financial statements filed with the Registrar of Companies (RoC). Founded in 2021 by Romita Mazumdar, Foxtale is an affordable skincare brand focused on products designed for Indian skin. Its products target issues such as acne, aging, and hyperpigmentation. The sale of skin and beauty products was Foxtale's sole source of revenue in the fiscal year. Including other income of Rs 7 crore, the company’s total income stood at Rs 206 crore during FY25. On the spending side, advertising cost accounted for 38% of the total expense. To the tune of scale, this cost more than doubled to Rs 106 crore in FY25 from Rs 50 crore in FY24. Cost of material also doubled to Rs 74 crore in FY25 from Rs 34 crore in FY24. Employee benefit expense increased by 55% to Rs 31 crore in the same period. Overall, Foxtale’s total expenses more than doubled to Rs 279 crore in FY25 from Rs 139 crore in FY24. The company’s net loss increased by 38% to Rs 73 crore in FY25 from Rs 55 crore in FY24. Its ROCE and EBITDA margin improved to -26.87% and -39.20% respectively. On a unit basis, Foxtale spent Rs 1.40 to earn a rupee of operating revenue in FY25, improving from Rs 1.67 in the previous fiscal year. Its cash and bank balance increased to Rs 166 crore in FY25 from Rs 43 crore in FY24, while current assets grew to Rs 316 crore. According to TheKredible, Foxtale has raised a total of $52 million of funding till date, having Matrix Partners and Kae Capital as its lead investors. The company’s Founder and CEO, Romita Mazumdar owns 34% of the company. Foxtale recently said that about 50% of purchases through its D2C website are from repeat customers. It also claimed that it is on track to end the year with an Annual Recurring Revenue (ARR) of over Rs 700 crore in GMV and expects to achieve profitability next year.

Download the medial app to read full posts, comements and news.